Target intelligence / Profile preview

Potassium channel subfamily K member 9 (TASK-3) (TASK-3)

Target
TASK-3
Molecular classification
Ion channel, Two-pore domain potassium channel
01

Overview

Potassium channel subfamily K member 9 (TASK-3) is a pH-sensitive, two-pore domain potassium (K2P) channel that contributes to the background leak current, thereby regulating the resting membrane potential and cellular excitability (UniProt Q9NPC2). It is predominantly expressed in the central nervous system, particularly in the cerebellum and thalamus, as well as in the adrenal cortex (PubMed: 11091877). TASK-3 is characterized by its sensitivity to extracellular acidification, which inhibits the channel, and its activation by volatile anesthetics like halothane (PubMed: 10864915). In oncology, TASK-3 is recognized as a proto-oncogene, with its gene (KCNK9) frequently amplified or overexpressed in breast, lung, and colon cancers, promoting tumor growth and resistance to hypoxia (PubMed: 12871971). Furthermore, a specific gain-of-function mutation (p.Gly236Arg) in KCNK9 causes Birk-Barel syndrome, a genomic imprinting disorder characterized by intellectual disability and hypotonia (PubMed: 18678291). Consequently, TASK-3 is a target for small-molecule inhibitors in cancer therapy and potential activators for neurological disorders.

Other names
KCNK9TASK3K2P9.1Acid-sensitive potassium channel protein 2Two pore potassium channel KT3.1
02

Mechanism of action

Modulation of potassium leak currents to control membrane potential and cellular excitability.

03

Biological functions

Maintenance of resting membrane potentialRegulation of neuronal excitabilitypH sensingApoptosis regulationCell proliferation
04

Disease associations

CancerBirk-Barel syndromeSleep apneaDepressionAldosteronism
05

Safety considerations

Off-target inhibition of TASK-1 channels due to high homologyPotential cardiovascular side effectsCNS-related adverse effects
06

Interacting drugs

PK-THPP

6 more in the full profile.

07

Biomarkers

KCNK9 gene amplificationKCNK9 protein expression levelsKCNK9 p.Gly236Arg mutation

Beyond the preview

Go deeper on Potassium channel subfamily K member 9 (TASK-3) (TASK-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K member 9 (TASK-3) (TASK-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call